Cell and Gene Therapy World Summit
11th -
June 2024 | 
London, UK

Enhanced CGT R&D & Manufacturing at Reduced Cost for Increased Market Access

11th -
June 2024 | 
London, UK
馃搯 Add to Google Calendar
0 +
0 +
0 +
0 +
In-Person Networking Hours
0 +
Case Studies

Cell and gene therapy are novel therapeutics that have attracted much attention amongst the global biomedical sectors for the treatment of diseases and physiological conditions due to their promising potential in addressing unmet medical needs.

Despite these breakthroughs, the field faces persistent challenges and must overcome technical and commercial hurdles to fully realise its potential. As part of the Cell and Gene Therapy World Series, the Cell & Gene Therapy World Summit 2024 brings together industry leaders to discuss best practices in R&D and Manufacturing. The conference aims to showcase the latest innovations, tackle challenges like immunogenicity, automation, and commercialisation, ultimately fostering the widespread availability of these transformative therapies.

Cell and Gene Therapy World Summit 2024

Explore different approaches of preclinical and clinical development such as proof-of-concept studies and extensive clinical research along with the latest developments in safety and efficacy, designing and implementing early-phase clinical trials and strategies for patient selection and recruitment. Learn about the pivotal role these processes play in ensuring that cell and gene therapies can be made available to patients as safe and effective treatment options.

Gain the current insights on cell and gene therapy manufacturing, strategies to streamline the manufacturing processes for improved efficiency and reduced cost along with techniques in cell expansion, cell culture and vector production. Find out how these practices accelerate the translation of scientific advancements into robust and reliable manufacturing processes for cell and gene therapies.

Review our collection of case studies highlighting significant achievements in the field of cell and gene therapy from across Europe, such as the development and commercialization of Strimvelis, and the clinical outcomes of Kymriah. These case studies will provide valuable insights for researchers, clinicians, and industry professionals engaged in the development and application of these transformative therapies.

Delve into our interactive and informative roundtable discussions which will feature topics from the聽Lessons from Cell and Gene Therapy Clinical Trials, Technology and Innovation in Cell and Gene Therapy, Overcoming Challenges in Commercialization聽along with聽Collaboration and Partnerships,聽Addressing Safety and Efficacy Concerns聽and聽The Future of Cell and Gene Therapy聽to name a few. Facilitated by industry experts, our discussions will provide an opportunity for delegates and speakers to network and connect while gaining the latest and more relevant insights into the cell and gene therapy industry.

Identify the advancements in gene editing tools, such as CRISPR/Cas9, that have significantly enhanced the precision and effectiveness of treatments by allowing for precise gene corrections, insertions, or deletions, offering unprecedented opportunities to address genetic diseases at their root cause and the advancements in vector design that have improved the delivery of therapeutic genes to target cells.

Learn about the novel therapies that aim to overcome existing limitations and expand the scope of treatment options for various diseases. Cutting-edge technologies, RNA-based therapeutics and advanced cell engineering are a few of the key innovations included, that are paving the way for more precise and targeted interventions. Find out how these next-generation treatments are poised to provide personalized, durable, and curative solutions for patients, offering hope for improved clinical outcomes and transforming the landscape of healthcare.



Featuring esteemed voices from the biopharmaceutical sector. Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Don't miss this chance to broaden your understanding of this ever-evolving industry.


Alain Vert茅s

Vice President Alliance Management & External Innovation


Alberto del R铆o Esp铆nola

Director in Toxicology

Alois Jungbuer

Alois Jungbauer

Professor, Institute of Bioprocess Science and Engineering, Department of Biotechnology

University of Natural Resources and Life Sciences

Anji Miller

Programme Director, LifeArc Technology Transfer Fellowship Programme

Arindam Mitra

Arindam Mitra

Director CMC

Leucid Bio

Ben Weil

CMC Director

InMune Bio
Charlotte Smerdon

Charlotte Smerdon

Senior Director Clinical Operations

Purespring Therapeutics
Elisa Agostini

Elisa Agostini

Associate Director, Global CMC Project Management

Orchard Therapeutics

Hemant Dhamne

Associate Director, Process Development

Autolus Ltd

Jonggu Kim

Leader, External Manufacturing Quality

South Korea
Lilian Hook

Lilian Hook

Director Cell, Apheresis and Gene Therapies,

NHS Blood and Transplant
Marina Tarunina

Marina Tarunina

Research Director

Plasticell Ltd
Michael von Forstner

Michael von Forstner

Head of Safety Science

Sobi - Swedish Orphan Biovitrum AB
Wigdahl, Nicholas

Nicholas Wigdahl

Head of Established Products, Roche Pharma Technical Services


Rasmus Beedholm-Ebsen

Senior Advisor - Life Science

Invest in Denmark (Ministry of Foreign Affairs of Denmark)
Rocky Cranenburgh

Rocky Cranenburgh

Chief Executive Officer and Founder

Bitrobius Genetics
Ross Bunyan

Ross Bunyan

Process Scientist

Resolution Therapeutics
image (3)

Tyler Goodwin

Director/Head of Delivery Technologies

Tune Therapeutics
Dina Du

Yue (Dina) Du

Senior Scientist



Catch the limited super access in time to save BIG!

Limited Super (By 22nd Feb 2024)
拢 850

Limited Special (By 19th April 2024)
拢 1,050 

Early Bird (By 10th May 2024)
拢 1,250

Standard Price
拢 1,450
Limited Group Packages
  • BUY2,GET3
  • BUY3,GET5
Limited Super (By 22nd Feb 2024)
拢 2,050

Limited Special (By 19th April 2024)
拢 2,250 

Early Bird (By 10th May 2024)
拢 2,450

Standard Price
拢 2,650
Group Discount for Solution Providers & General Public: 
Buy 3 and get 10% off, Buy 5 get 20% off, Buy 6 and above, get 25% off


Blueprint Of Success: Download CGTWS Previous Event Report
CGTWS24_ebook Download_linkein
Optimizing Cell & Gene R&D, Streamlining Manufacturing, and Expanding Market Access in Europe
CDMO Geographical Distribution Infographic
[Webcast] Advancing Cell & Gene Therapy: Current Landscape and Future Outlook
Revolutionizing Healthcare: Cell & Gene Therapy In UK



Download Post Event Report Form

Download Attendee List

Download Prospectus Document Form

Download Brochure Document Form

Sponsorship Form

Download Agenda Form

Apply For Speaking Opportunity

Download Featured Content Form

Download List of Biopharma, CMO, CRO, CDMO and Big Pharma in China and Taiwan Brochure

Download Strategic Consulting Brochure

Download Case Study Consulting Digital Disruption

Download Case Study Consulting Revolutionizing Biopharmaceuticals

Download IMAPAC Custom Events Prospectus

Download Case Study : Fill-Finish Solution provider increasing its market share

Download Case Study : European CMO expanding into APAC

Download Case Study : China CDMO's New Gene Protein Facility Opening

Download Biologics Newsletter

Download Cell and Gene Therapy Newsletter

Download Vaccines Newsletter

Download 1:1 Networking Meetings Case Study- High-end assembly solutions provider

Download 1:1 Networking Meetings Case Study- IT/Software Solution provider

Download 1:1 Networking Meetings Case Study- Biopharma Courier Service Provider

Download Ebook

Download Ebook

Download Events Calendar

Customised Webinar/Webcast

Download Customised Events Brochure

Contact us for Third Party Email Services

Download Newsletter Press Kit